세계 혈액형 검사 시장은 2023년 20억 1,000만 달러로 2029년까지 연평균 8.76% 성장할 것으로 예측됩니다.
혈액형 판정이라고도 하는 혈액형 검사는 적혈구(RBC) 표면에 존재하는 특정 혈액형 항원과 혈장에 존재하는 해당 항체를 식별하는 데 사용되는 검사 방법입니다. 주요 혈액형에는 ABO와 Rh형이 있지만, 혈액형 검사로 식별할 수 있는 부수적인 혈액형도 많이 있습니다. 기증자의 혈액형과 수혜자의 혈액형을 일치시키는 것은 수혈 시 부작용을 예방하는 데 매우 중요합니다. 혈액형이 맞지 않는 수혈은 용혈반응을 일으켜 생명을 위협할 수 있습니다. 장기 기증자와 장기 수혜자의 혈액형 일치는 장기 거부반응을 예방하고 성공적인 장기 이식을 위해 필수적입니다. 산모와 태아의 혈액형 부적합으로 인한 신생아 용혈성 질환(HDN)의 잠재적 위험을 파악하기 위해 임산부의 혈액형 검사는 필수적입니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2025-2029년 |
| 시장 규모 : 2023년 | 20억 1,000만 달러 |
| 시장 규모 : 2029년 | 33억 3,000만 달러 |
| CAGR : 2024-2029년 | 8.76% |
| 급성장 부문 | 어세이 기반 기술 |
| 최대 시장 | 북미 |
전 세계적으로 만성 질환, 수술 및 외상 환자가 증가함에 따라 수혈에 대한 수요가 증가하고 있습니다. 정확한 혈액형 판별은 공여자와 수혜자 혈액의 적합성을 보장하는 데 필수적이며, 혈액형 검사 제품 및 서비스의 필요성이 증가하고 있습니다. 분자진단, 자동화, 현장 검사 등 혈액형 검사 방법의 기술적 발전으로 혈액형 검사의 정확성, 속도, 효율성이 향상되고 있습니다. 이러한 발전은 혈액형 검사 서비스의 신뢰성과 접근성을 높여 시장 성장을 촉진하고 있습니다. 개인 맞춤형 의료와 맞춤형 치료로의 전환은 수혈 및 이식 의료에서 정확한 혈액형 분류의 중요성을 강조하고 있습니다. 혈액형 검사를 통해 의료 서비스 제공자는 특정 유전자 프로필에 따라 혈액 제제 및 장기를 수혜자와 일치시켜 치료 결과를 개선하고 부작용의 위험을 줄일 수 있습니다. 특히 신흥국의 혈액은행 인프라 확충이 세계 혈액형 검사 시장의 성장을 견인하고 있습니다. 의료 인프라에 대한 투자 증가, 헌혈 캠페인, 혈액 처리 시설의 설립은 다양한 의료 환경에서 혈액형 검사 서비스를 이용할 수 있게 하는 데 기여하고 있습니다. 세계 헬스케어 지출 증가와 의료 접근성 및 품질 향상을 위한 정부 이니셔티브가 결합되어 첨단 혈액형 검사 기술 및 서비스 채택을 확대함으로써 시장 성장을 촉진하고 있습니다. 의료 서비스 제공자들은 수혈 및 이식 서비스에 대한 수요 증가에 대응하기 위해 혈액형 검사 역량을 업그레이드하는 데 자원을 할당하고 있습니다.
혈액형 검사 기술의 발전
수혈 수요의 증가
혈액은행 인프라 확대
혈액형 시스템의 복잡성
고정확도, 고정밀도의 필요성
헌혈에 대한 노력의 증가
Global Blood Group Typing Market was valued at USD 2.01 billion in 2023 and will see an impressive growth in the forecast period at a CAGR of 8.76% through 2029. Blood group typing, also known as blood typing, is a laboratory method used to identify the specific blood group antigens present on the surface of red blood cells (RBCs) and the corresponding antibodies present in the plasma. The primary blood group systems include the ABO system and the Rh system, but there are many other minor blood group systems that can also be identified through blood typing. Matching the blood type of the donor with that of the recipient is critical to prevent adverse reactions during blood transfusions. Incompatible blood transfusions can lead to hemolytic reactions, which can be life-threatening. Blood group compatibility between organ donors and recipients is necessary to prevent organ rejection and ensure the success of organ transplantation procedures. Blood group typing of pregnant women is essential to identify any potential risks of hemolytic disease of the newborn (HDN) due to blood group incompatibilities between the mother and fetus.
| Market Overview | |
|---|---|
| Forecast Period | 2025-2029 |
| Market Size 2023 | USD 2.01 Billion |
| Market Size 2029 | USD 3.33 Billion |
| CAGR 2024-2029 | 8.76% |
| Fastest Growing Segment | Assay-Based Techniques |
| Largest Market | North America |
The rising prevalence of chronic diseases, surgical procedures, and trauma cases worldwide has led to a growing demand for blood transfusions. Accurate blood group typing is essential to ensure compatibility between donor and recipient blood, driving the need for blood typing products and services. Technological advancements in blood typing methods, such as molecular diagnostics, automation, and point-of-care testing, have improved the accuracy, speed, and efficiency of blood typing procedures. These advancements drive market growth by enhancing the reliability and accessibility of blood typing services. The shift towards personalized medicine and tailored treatment approaches emphasizes the importance of precise blood group typing in transfusion and transplantation medicine. Blood typing enables healthcare providers to match blood products and organs with recipients based on their specific genetic profiles, improving treatment outcomes and reducing the risk of adverse reactions. The expansion of blood banking infrastructure, especially in emerging economies, supports the growth of the global blood group typing market. Increasing investments in healthcare infrastructure, blood donation campaigns, and the establishment of blood processing facilities contribute to the availability of blood typing services in diverse healthcare settings. The increasing healthcare expenditure globally, coupled with government initiatives to improve healthcare accessibility and quality, drives market growth by expanding the adoption of advanced blood typing technologies and services. Healthcare providers allocate resources towards upgrading blood typing capabilities to meet the growing demand for transfusion and transplantation services.
Key Market Drivers
Advancements in Blood Typing Technologies
Molecular typing methods, such as polymerase chain reaction (PCR) and nucleic acid sequencing, enable the detection and identification of specific genetic markers associated with different blood groups. These methods offer high levels of accuracy and precision, particularly in identifying rare or complex blood group antigens. Automation and robotics have revolutionized blood typing laboratories by streamlining workflows, reducing human error, and increasing throughput. Automated platforms perform blood typing assays, sample handling, and data analysis with minimal manual intervention, improving efficiency and standardization in blood typing procedures.
Point-of-care testing devices allow for rapid blood typing and compatibility testing at the bedside or in remote settings, such as emergency departments, ambulances, and field hospitals. POCT devices provide real-time results, enabling prompt decision-making for blood transfusions and emergency medical interventions. Multiplex assays simultaneously detect multiple blood group antigens and antibodies in a single test, offering comprehensive blood typing profiles in a shorter time frame. These assays enhance efficiency, conserve sample volume, and facilitate the identification of complex blood group phenotypes. High-throughput screening platforms enable the simultaneous analysis of large numbers of blood samples, making them well-suited for blood typing in blood banks, donor centers, and large-scale screening programs. These platforms leverage advanced technologies, such as microarrays and flow cytometry, to expedite blood typing processes and enhance laboratory productivity.
Next-generation sequencing techniques allow for the comprehensive analysis of blood group genes and genetic variations associated with blood group antigens. NGS platforms offer high resolution and sensitivity, enabling the detection of novel blood group alleles and facilitating precise blood typing in diverse patient populations. Bioinformatics tools and data analysis algorithms play a crucial role in interpreting complex blood typing data, identifying genetic variants, and predicting blood group phenotypes. These tools enable researchers and healthcare providers to analyze large datasets, uncover genotype-phenotype associations, and improve the accuracy of blood typing results. Customized testing panels allow laboratories to tailor blood typing assays based on specific clinical requirements, patient populations, and testing objectives. Customization options include selecting target antigens, optimizing assay parameters, and integrating complementary testing methodologies to meet diverse clinical needs. This factor will help in the development of the Global Blood Group Typing Market.
Increasing Demand for Blood Transfusions
Blood group typing is essential to ensure compatibility between donor blood and recipient blood during transfusions. Knowing the blood type of both the donor and recipient helps prevent adverse reactions, such as transfusion reactions or hemolytic reactions, which can be life-threatening. Transfusion reactions can occur when incompatible blood types are transfused into recipients. Blood group typing helps identify the presence of antigens on red blood cells and antibodies in plasma, allowing healthcare providers to select compatible blood products and minimize the risk of transfusion reactions. Accurate blood group typing facilitates precise matching of donor blood to recipient blood, ensuring that the transfused blood is compatible and safe for the patient. This is particularly crucial for patients who require frequent or ongoing transfusions due to medical conditions such as anemia, cancer, or surgical procedures.
Blood group typing contributes to patient safety by reducing the likelihood of transfusion-related complications and adverse events. By accurately identifying blood types and matching blood products, healthcare providers can minimize the risks associated with transfusions and improve patient outcomes. The increasing demand for blood transfusions reflects the growing healthcare needs of populations worldwide. Factors such as aging populations, advances in medical treatments, and rising incidences of trauma and chronic diseases contribute to the rising demand for blood products and blood typing services. Blood transfusions are often required in emergency medical situations, such as trauma cases, surgical emergencies, and obstetric complications. Rapid and accurate blood group typing is essential in these scenarios to facilitate timely transfusions and save lives. Public health initiatives aimed at increasing blood donation rates and ensuring the availability of safe blood products further drive the demand for blood group typing services. Blood typing is an integral part of blood screening protocols to maintain the safety and quality of the blood supply. This factor will pace up the demand of the Global Blood Group Typing Market
Expansion of Blood Banking Infrastructure
With the expansion of blood banking infrastructure, including the establishment of new blood banks and donation centers, there is a greater volume of blood collected and processed for transfusion purposes. Blood banks require comprehensive blood group typing services to ensure the compatibility of donated blood with potential recipients. The expansion of blood banking infrastructure often leads to increased diversity in the donor pool, with donors from different ethnic, racial, and geographic backgrounds. As a result, there is a greater need for comprehensive blood group typing services to accurately characterize the diverse range of blood types present in the donor population. Blood banks play a crucial role in emergency preparedness and response efforts during natural disasters, mass casualty incidents, and other emergencies. Rapid and accurate blood group typing services are essential for quickly assessing the available blood inventory, identifying compatible blood products, and addressing the transfusion needs of patients in emergency situations. Blood banking infrastructure expansion involves the implementation of sophisticated blood supply management systems to track blood inventory, monitor expiration dates, and optimize blood distribution. Blood group typing services are integral to these management systems, providing essential data for inventory management and ensuring the availability of compatible blood products when needed.
Blood banks are subject to stringent regulatory requirements and quality assurance standards to maintain the safety, efficacy, and integrity of the blood supply. Blood group typing services play a critical role in ensuring regulatory compliance by accurately characterizing blood types, screening for infectious diseases, and performing compatibility testing in accordance with regulatory guidelines. The expansion of blood banking infrastructure enables the production and distribution of specialized blood products, such as frozen plasma, platelets, and cryoprecipitate, for specific clinical indications and patient populations. Blood group typing services are essential for characterizing these specialized blood products and ensuring their compatibility with recipient blood. Advances in transfusion medicine, including the development of novel blood products, transfusion protocols, and therapeutic approaches, drive the demand for blood group typing services. Blood group typing facilitates personalized transfusion strategies tailored to individual patient needs, improving transfusion outcomes and patient safety. This factor will accelerate the demand of the Global Blood Group Typing Market
Key Market Challenges
Complexity of Blood Group Systems
Blood group systems encompass a wide range of antigens present on the surface of red blood cells. These antigens can vary significantly in terms of their molecular structure, distribution in different populations, and clinical significance. The diversity of blood group antigens complicates blood typing procedures and requires comprehensive testing methodologies to accurately characterize blood types. Some blood group antigens are rare or uncommon, making them challenging to detect using traditional serological methods. Identifying and typing rare antigens require specialized reagents, advanced testing techniques, and expertise in immunohematology, increasing the complexity and cost of blood typing procedures. Blood group antigens may exhibit variability in expression levels, genetic polymorphisms, and antigenic determinants among individuals and populations. This variability can lead to discrepancies in blood typing results, false-negative or false-positive reactions, and challenges in interpreting blood group phenotypes accurately.
Need for High Accuracy and Precision
Ensuring the accuracy of blood group typing is critical for patient safety during blood transfusions. Inaccurate blood typing results can lead to transfusion reactions, hemolytic episodes, and other adverse events that jeopardize patient health and well-being. Mismatched blood transfusions due to inaccurate blood typing can result in severe transfusion reactions, including hemolytic reactions, allergic reactions, and acute immune-mediated complications. The potential consequences of transfusion reactions underscore the importance of achieving high accuracy and precision in blood typing procedures. Blood group typing involves the characterization of complex blood group systems, including the ABO system, Rh system, and numerous minor blood group antigens. The diverse range of antigens and their genetic variants increase the complexity of blood typing assays and require meticulous attention to detail to ensure accuracy and precision. Serological blood typing assays rely on the interpretation of antigen-antibody reactions, which can be subject to interpretation variability and subjective judgment. Achieving consistent and reproducible results across different laboratory settings requires standardized protocols, quality control measures, and ongoing training for laboratory personnel.
Key Market Trends
Increasing Blood Donation Initiatives
Blood donation initiatives aim to increase the number of voluntary blood donors, thereby expanding the pool of available blood products for transfusion. A larger donor pool enhances the availability of diverse blood types, facilitating better matching and compatibility with recipients. Encouraging blood donation from a diverse range of donors helps ensure the availability of blood products with various blood types and antigen profiles. This diversity is crucial for meeting the transfusion needs of patients with specific blood group requirements, including those with rare or uncommon blood types. Blood donation initiatives contribute to maintaining an adequate and stable blood supply, which is essential for meeting the demands of healthcare facilities and responding to emergency situations, such as natural disasters, mass casualty incidents, and pandemics. Increasing blood donation rates supports transfusion safety by reducing the reliance on directed or replacement blood donations, which may carry a higher risk of transfusion-transmitted infections and other adverse events. Voluntary blood donation programs promote a culture of altruism, community engagement, and public health awareness regarding the importance of blood donation and transfusion safety.
Segmental Insights
Technique Insights
The Assay-Based Techniques segment is projected to experience rapid growth in the Global Blood Group Typing Market during the forecast period. Assay-based techniques, such as polymerase chain reaction (PCR), microarray analysis, and flow cytometry, offer high levels of accuracy and precision in blood group typing. These techniques allow for the detection of specific genetic markers and antigen profiles associated with different blood groups, enabling more reliable and consistent typing results. Assay-based techniques are often automated and capable of high throughput, allowing for the rapid processing of large numbers of samples in a relatively short period. This scalability and efficiency make assay-based methods well-suited for blood typing in blood banks, hospitals, and clinical laboratories with high testing volumes. Assay-based techniques enable the identification and typing of a broader range of blood group antigens beyond the ABO and Rh systems. This expanded antigen typing capability is particularly valuable in situations where comprehensive blood group matching is required for blood transfusions, organ transplantation, and prenatal testing.
Test Type Insights
The Antibody Screening segment is projected to experience rapid growth in the Global Blood Group Typing Market during the forecast period. With a growing number of blood transfusions being performed worldwide, there is a heightened emphasis on ensuring the safety and compatibility of blood products. Antibody screening plays a critical role in identifying antibodies in patient blood samples, which helps prevent transfusion reactions and ensures patient safety during blood transfusions. The prevalence of chronic diseases such as cancer, autoimmune disorders, and blood disorders is on the rise globally. Patients with these conditions often require frequent blood transfusions as part of their treatment regimens. Antibody screening is essential for identifying potential alloantibodies in these patients, which may develop because of previous transfusions or pregnancies. Advances in laboratory techniques and technologies have made antibody screening more efficient, sensitive, and cost-effective. Newer screening assays and automated platforms allow for high-throughput screening of patient samples, reducing turnaround times and improving workflow efficiency in blood typing laboratories.
Regional Insights
North America emerged as the dominant region in the Global Blood Group Typing Market in 2023. North America boasts advanced healthcare infrastructure, including state-of-the-art laboratories, well-equipped healthcare facilities, and sophisticated blood typing technologies. This enables healthcare providers in the region to offer comprehensive blood typing services with high levels of accuracy and efficiency. The region is a hub for technological innovation and research in healthcare, including blood group typing. North American companies and research institutions continually invest in developing cutting-edge blood typing technologies, enhancing testing methodologies, and improving overall patient care outcomes. North America has stringent regulatory standards and quality control measures governing blood typing practices. Compliance with these standards ensures the safety, accuracy, and reliability of blood typing tests, contributing to the region's reputation for high-quality healthcare services. North America has a robust blood donation infrastructure supported by active participation from blood banks, healthcare organizations, and community-based initiatives. The availability of a steady supply of blood products facilitates timely blood typing and transfusion services, meeting the needs of patients across diverse healthcare settings.
Thermo Fisher Scientific Inc.
Danaher Corporation
Illumina, inc.
Immucor, inc.
CareDx Inc.
Mesa Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Merck KgaA
AliveDx Suisse SA
QuidelOrtho Corporation
In this report, the Global Blood Group Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
United States
Canada
Mexico
Germany
United Kingdom
France
Italy
Spain
China
Japan
India
Australia
South Korea
Brazil
Argentina
Colombia
South Africa
Saudi Arabia
UAE
Company Profiles: Detailed analysis of the major companies present in the Global Blood Group Typing Market.
Global Blood Group Typing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to five).